Table 1 Overview of the study population
Mean ± SD median (min-max) IQR | ||||
|---|---|---|---|---|
Whole population | Patients with type 1 diabetes | Healthy volunteers | p-value | |
Sex | ||||
Male | 20 (66.7%) | 10 (66.7%) | 10 (66.7%) | 1.0 |
Female | 10 (33.3%) | 5 (33.3%) | 5 (33.3%) | |
Age [years] | 31.8 ± 9.6 | 32.1 ± 9.5 | 31.4 ± 10.1 | 0.9006 |
30 (20.0–54.0) | 30.0 (20.0–50.0) | 28.0 (21.0–54.0) | ||
17,0 | 17,0 | 17,0 | ||
BMI [kg/m2] | 23.7 ± 2.7 | 24.3 ± 3.0 | 23.3 ± 2.4 | 0.3947 |
22.9 (19.9–29.4) | 24.8 (19.9–29.4) | 22.3 (20.8–28.9) | ||
3,7 | 5,1 | 3,0 | ||
Duration of diabetes [months] | 45.7 ± 42.3 | |||
25.0 (5.0–125.0) | ||||
61,0 | ||||
HbA1c [%] | 6.7 ± 0.9 | 5.2 ± 0.2 | < 0.0001 | |
7.0 (5.4–8.0) | 5.2 (4.8–5.6) | |||
1,5 | 0,3 | |||
Fasting glucose [mg/dl] | 111.2 ± 37.0 | 90.0 ± 7.8 | 0.0777 | |
102.0 (66.0–191.0) | 89.0 (73.0–104.0) | |||
51,0 | 11,0 | |||
C peptidea [μg/l] | 0.9 ± 0.7 | 1.6 ± 0.5 | 0.0082 | |
0.7 (0.1–2.0) | 1.6 (0.8–2.8) | |||
1,1 | 0,4 | |||
Basal insulin (IU/d] | 13.9 ± 7.4 | |||
12.0 (2.0–30.0) | ||||
11,0 | ||||